PL442642A1 - Method of producing a nutraceutical with immunomodulating and immunostimulating properties for the immune system and the nutraceutical produced using this method - Google Patents

Method of producing a nutraceutical with immunomodulating and immunostimulating properties for the immune system and the nutraceutical produced using this method

Info

Publication number
PL442642A1
PL442642A1 PL442642A PL44264222A PL442642A1 PL 442642 A1 PL442642 A1 PL 442642A1 PL 442642 A PL442642 A PL 442642A PL 44264222 A PL44264222 A PL 44264222A PL 442642 A1 PL442642 A1 PL 442642A1
Authority
PL
Poland
Prior art keywords
sup
raw material
cfu
nutraceutical
total number
Prior art date
Application number
PL442642A
Other languages
Polish (pl)
Inventor
Daria Szymanowska
Original Assignee
Uniwersytet Przyrodniczy W Poznaniu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Przyrodniczy W Poznaniu filed Critical Uniwersytet Przyrodniczy W Poznaniu
Priority to PL442642A priority Critical patent/PL442642A1/en
Publication of PL442642A1 publication Critical patent/PL442642A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481Astragalus (milkvetch)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539Scutellaria (skullcap)

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Przedmiotem zgłoszenia jest sposób wytwarzania nutraceutyku o właściwościach immunomodulujących i immunostymulujących układ odpornościowy charakteryzujący się tym, że do mieszalnika wprowadza się cyklodekstrynę o wilgotności nie wyższej niż 9 – 11%, następnie dodaje się do niej kolejno susz z traganka błoniastego, otrzymanego na drodze suszenia konwekcyjnego bądź sublimacyjnego, o zawartość suchej masy surowca 85 - 90% i wysokiej czystości mikrobiologicznej tj. ogólna liczba bakterii mezofilnych < 10<sup>2</sup> jtk/gram surowca ogólna liczba bakterii psychrofilnych < 10<sup>2</sup> jtk/g surowca, liczba pleśni i drożdży < 10<sup>2</sup> jtk/g; Bacillus cereus — nieobecne w 1 g surowca, E.coli nieobecne w 1 g surowca, w postaci proszku rozdrobnionego do cząstek nie mniejszych niż 0,5 mm i nie większych niż 0,7 mm, i miesza się z prędkością 100 obr./min, po czym dodaje się susz z tarczycy bajkalskiej otrzymany na drodze suszenia konwekcyjnego lub sublimacyjnego (o zawartości suchej masy w przedziale od 85 do 90% i wysokiej czystości mikrobiologicznej tj. ogólna liczba bakterii mezofilnych < 10<sup>2</sup> jtk/gram surowca ogólna liczba bakterii psychrofilnych < 10<sup>2</sup> jtk/g surowca, liczba pleśni i drożdży < 10<sup>2</sup> jtk/g; Bacillus cereus - nieobecne w 1 g surowca, E. coli nieobecne w 1 g surowca), w postaci proszku o wielkości cząstek nie mniejszych niż 0,7 mm i nie większych niż 0,8 mm, całość miesza się, do uzyskania jednolitej mieszaniny, a następnie gotowy produkt konfekcjonuje się do żelatynowych kapsułek twardych po nie więcej niż 320 mg, co odpowiada jednej porcji produktu.The subject of the application is a method for producing a nutraceutical with immunomodulating and immunostimulating properties of the immune system, characterized by the fact that cyclodextrin with a humidity of not more than 9 - 11% is introduced into the mixer, then dried astragalus, obtained by convection drying or drying, is successively added to it. sublimation, with a raw material dry matter content of 85 - 90% and high microbiological purity, i.e. total number of mesophilic bacteria < 10<sup>2</sup> cfu/gram of raw material, total number of psychrophilic bacteria < 10<sup>2</sup> cfu /g of raw material, number of molds and yeasts < 10<sup>2</sup> cfu/g; Bacillus cereus - absent in 1 g of raw material, E. coli absent in 1 g of raw material, in the form of powder crushed to particles not smaller than 0.5 mm and not larger than 0.7 mm, and mixed at a speed of 100 rpm , then the dried Baikal skullcap obtained by convection or freeze drying is added (with dry matter content ranging from 85 to 90% and high microbiological purity, i.e. total number of mesophilic bacteria < 10<sup>2</sup> cfu/ gram of raw material, total number of psychrophilic bacteria < 10<sup>2</sup> cfu/g of raw material, number of molds and yeasts < 10<sup>2</sup> cfu/g; Bacillus cereus - absent in 1 g of raw material, E. coli absent in 1 g of raw material), in the form of a powder with a particle size not smaller than 0.7 mm and not larger than 0.8 mm, all mixed until a uniform mixture is obtained, and then the finished product is packaged into hard gelatin capsules after no more than 320 mg, which corresponds to one serving of the product.

PL442642A 2022-10-26 2022-10-26 Method of producing a nutraceutical with immunomodulating and immunostimulating properties for the immune system and the nutraceutical produced using this method PL442642A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL442642A PL442642A1 (en) 2022-10-26 2022-10-26 Method of producing a nutraceutical with immunomodulating and immunostimulating properties for the immune system and the nutraceutical produced using this method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL442642A PL442642A1 (en) 2022-10-26 2022-10-26 Method of producing a nutraceutical with immunomodulating and immunostimulating properties for the immune system and the nutraceutical produced using this method

Publications (1)

Publication Number Publication Date
PL442642A1 true PL442642A1 (en) 2024-04-29

Family

ID=90885639

Family Applications (1)

Application Number Title Priority Date Filing Date
PL442642A PL442642A1 (en) 2022-10-26 2022-10-26 Method of producing a nutraceutical with immunomodulating and immunostimulating properties for the immune system and the nutraceutical produced using this method

Country Status (1)

Country Link
PL (1) PL442642A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103054947A (en) * 2013-01-18 2013-04-24 广西壮族自治区海洋研究所 Pharmaceutical composition for preventing and treating trachinotus ovatus scabies disease
CN103142842A (en) * 2013-04-07 2013-06-12 龚定军 Traditional Chinese medicine for treating diabetes mellitus
PL236876B1 (en) * 2016-06-15 2021-02-22 Witpol Spolka Z Ograniczona Odpowiedzialnoscia Antioxidant mixture

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103054947A (en) * 2013-01-18 2013-04-24 广西壮族自治区海洋研究所 Pharmaceutical composition for preventing and treating trachinotus ovatus scabies disease
CN103142842A (en) * 2013-04-07 2013-06-12 龚定军 Traditional Chinese medicine for treating diabetes mellitus
PL236876B1 (en) * 2016-06-15 2021-02-22 Witpol Spolka Z Ograniczona Odpowiedzialnoscia Antioxidant mixture

Similar Documents

Publication Publication Date Title
Sharifi et al. Use of whey protein isolate and gum Arabic for the co-encapsulation of probiotic Lactobacillus plantarum and phytosterols by complex coacervation: Enhanced viability of probiotic in Iranian white cheese
Fritzen-Freire et al. Microencapsulation of bifidobacteria by spray drying in the presence of prebiotics
EP2730646B2 (en) Drying lactic acid bacteria and new compositions
Liu et al. Chitosan entrapping of sodium alginate/Lycium barbarum polysaccharide gels for the encapsulation, protection and delivery of Lactiplantibacillus plantarum with enhanced viability
CN108347982A (en) Stable dry probiotic composition for special dietary use
BRPI0711839A2 (en) probiotic microorganism compositions, granules containing them, preparation process and uses thereof
CN108523137A (en) A kind of preparation method of the probiotic granulate of acid and bile salt tolerance
MX2011002045A (en) Bacterial Composition.
TWI542284B (en) Granule containing livestock&#39;s blood and sheel as additives for fish feed or formula feed and manufacturing method of it
UA81225C2 (en) Solid composition containing bacillus-type non-pathogenic bacterial spores
Al-Hamayda et al. Utilizing date pits in microencapsulation: Effect of different variations on probiotic survivability under in-vitro digestion
Sansone et al. Particle technology applied to a lactose/NaCMC blend: Production and characterization of a novel and stable spray-dried ingredient
AU2013276851B2 (en) Method for the production of a porous powder product containing a probiotic or other microorganisms
PL442642A1 (en) Method of producing a nutraceutical with immunomodulating and immunostimulating properties for the immune system and the nutraceutical produced using this method
CN106942448A (en) A kind of preparation method of Sugarless type matrimony vine freeze-dried powder pressed candy
Lee et al. Dual use of a biopolymer from durian (Durio zibethinus) seed as a nutrient source and stabilizer for spray dried Lactobacillus plantarum
US20250019643A1 (en) Improved stability of microbial composition, and manufacturing methods therefore
Ardsiri et al. Survival of probiotics Lactobacillus acidophilus TISTR1338 in a synbiotic-supplemented plant-based protein powder under various pH and temperatures
Khoothiam et al. Probiotic encapsulation in CaCO3 microparticles: Enhancement of viability under heat treatments and simulated gastrointestinal conditions
AU2018244082A1 (en) Process for the preparation of powdered probiotic formulations for monograstic animals.
Petsong et al. Impact of bio-calcium from Nile tilapia bone as a supporting material on the stability enhancement of immobilized probiotics
Lavanya et al. Chitosan based ecofriendly nanoencapsulation formulation of Clitoria ternatea extract coated bacterial probiotic strain Lactobacillus acidophilus: a sustainable approach to improve probiotic functionality, stability, and tolerance
US20250019639A1 (en) Fat and wax microencapsulated ambient stable bacteria and probiotics
JP7575424B2 (en) Compositions and methods of manufacture
CN118475254A (en) Composition for improving stability of bacteria